Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)
Clinical trial NCT01464476 · TERMINATED
Trial details
- NCT number
- NCT01464476
- Sponsor
- Forest Laboratories
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-05-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.